Asbestos Research Today is a free monthly online journal that collates and summarizes the latest research about Asbestos, including details on mesothelioma, lung disease, dangers, effects, risks.

Volume 2 (2005), Issue 9 (September)

1. Serum PDGF-AB in pleural mesothelioma.
   Tumour Biol, 26(5): 221-6. [Abstract] [Full-text]
2. Triplet chemotherapy with cisplatin, gemcitabine and vinorelbine for malignant pleural mesothelioma.
   Jpn J Clin Oncol, 35(8): 433-8. [Abstract] [Full-text]
3. Human and mouse mesotheliomas exhibit elevated AKT/PKB activity, which can be targeted pharmacologically to inhibit tumor cell growth.
   Oncogene, 24(40): 6080-9. [Abstract] [Full-text]
4. Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada.
   J Clin Oncol, 23(28): 6881-9. [Abstract] [Full-text]

© 2004-2008 Asbestos Research Today. All Rights Reserved.